Publicaciones en colaboración con investigadores/as de Hospital Universitari de Girona Dr. Josep Trueta (15)

2024

  1. Revascularization and outcomes in ischaemic left ventricular dysfunction after heart failure admission: The RevascHeart study

    European Journal of Heart Failure

2023

  1. Changes in echocardiographic parameters over time in paradoxical low-flow low-gradient aortic stenosis

    European heart journal. Cardiovascular Imaging, Vol. 24, Núm. 8, pp. 1120-1128

2021

  1. Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction

    Journal of the American College of Cardiology, Vol. 78, Núm. 7, pp. 643-662

2020

  1. FRAIL Scale also Predicts Long-Term Outcomes in Older Patients With Acute Coronary Syndromes

    Journal of the American Medical Directors Association, Vol. 21, Núm. 5, pp. 683-687.e1

  2. Impact of Diabetes Mellitus and Frailty on Long-Term Outcomes in Elderly Patients with Acute Coronary Syndromes

    Journal of Nutrition, Health and Aging, Vol. 24, Núm. 7, pp. 723-729

2019

  1. Criteria for admitting elderly patients with acute coronary syndrome to critical care units from Spanish hospital emergency departments: a LONGEVO-SCA cohort study

    Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 31, Núm. 3, pp. 154-160

  2. Persistence with dual antiplatelet therapy after percutaneous coronary intervention for ST-segment elevation acute coronary syndrome: A population-based cohort study in Catalonia (Spain)

    BMJ Open, Vol. 9, Núm. 7

  3. Statin Treatment and Prognosis of Elderly Patients Discharged after Non-ST Segment Elevation Acute Coronary Syndrome

    Cardiology (Switzerland), Vol. 143, Núm. 1, pp. 14-21

2018

  1. An Easy Assessment of Frailty at Baseline Independently Predicts Prognosis in Very Elderly Patients With Acute Coronary Syndromes

    Journal of the American Medical Directors Association, Vol. 19, Núm. 4, pp. 296-303

  2. Global Geriatric Assessment and In-Hospital Bleeding Risk in Elderly Patients with Acute Coronary Syndromes: Insights from the LONGEVO-SCA Registry

    Thrombosis and Haemostasis, Vol. 118, Núm. 3, pp. 581-590

2016

  1. Interhospital Variability in Drug Prescription after Acute Coronary Syndrome: Insights from the ACDC Study

    Revista Espanola de Cardiologia, Vol. 69, Núm. 2, pp. 117-124

2015

  1. Clinical development of rivaroxaban: Emerging new clinical evidences?

    Future Cardiology, Vol. 11, Núm. 5, pp. 565-583

2013

  1. Fracción aminoterminal del propéptido natriurético cerebral y troponina ultrasensible en el dolor torácico agudo de origen incierto. Un subestudio del estudio PITAGORAS

    Revista Espanola de Cardiologia, Vol. 66, Núm. 7, pp. 532-538

2012

  1. Usefulness of high-sensitivity troponin T for the evaluation of patients with acute chest pain and no or minimal myocardial damage

    American Heart Journal, Vol. 164, Núm. 2

2010

  1. Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation

    Circulation, Vol. 122, Núm. 10, pp. 1017-1025